Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats (Q34147832)

31 July 2017

title

Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats (English)

1 reference

31 July 2017

P Brański

3

0 references

Bernadeta Szewczyk

B Szewczyk

6

0 references

Gabriel Nowak

G Nowak

4

0 references

Andrzej Pilc

A Pilc

1

0 references

Joanna Wierońska

9

J M Wierońska

1 reference

31 July 2017

8

E Chojnacka-Wójcik

1 reference

31 July 2017

7

E Tatarczyńska

1 reference

31 July 2017

A Kłodzińska

2

1 reference

31 July 2017

A Pałucha

5

1 reference

31 July 2017

publication date

1 August 2002

1 reference

31 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

31 July 2017

volume

43

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

181-187

1 reference

Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

The prevalence of psychiatric disorders in a primary care practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Antidepressant effects of ketamine in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Olfactory projection systems, drugs and behaviour: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Pharmacology and functions of metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Activation of metabotropic glutamate receptors produces reciprocal regulation of ionotropic glutamate and GABA responses in the nucleus of the tractus solitarius of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

The three faces of the antidepressants: a critical commentary on the clinical-economic context of diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Animal models of depression: parallels and correlates to severe depression in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

A role for glutamate in the treatment of anxiety and depression: Focus on group I metabotropic glutamate (mGlu) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

The metabotropic glutamate receptors: structure and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Tolerance to anxiolytic- and antidepressant-like effects of a partial agonist of glycineB receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Antidepressants for the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Current perspectives on the development of non-biogenic amine-based antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Glutamate release inhibiting properties of the novel mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Metabotropic glutamate autoreceptors of the mGlu(5) subtype positively modulate neuronal glutamate release in the rat forebrain in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

A simple and reliable conflict procedure for testing anti-anxiety agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Modulation of glutamate receptors: molecular mechanisms and functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

An antidepressant-induced decrease in the responsiveness of hippocampal neurons to group I metabotropic glutamate receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0028-3908(02)50082-5

10.1016/S0028-3908(02)00082-5

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference